Is Premenstrual Syndrome Worse With PCOS?

Women with polycystic ovary syndrome experience premenstrual symptoms that are, on average, more frequent and more severe than those reported by women without the condition. A nationwide Swedish study tracking tens of thousands of individuals over a median of fifteen years found that PCOS raised the risk of developing a clinically recognized premenstrual disorder by roughly 50 to 60 percent, even after adjusting for obesity, socioeconomic factors, and psychiatric history. The reasons involve several overlapping hormonal and metabolic disruptions that PCOS introduces, and the practical consequences for daily life can be substantial.

What Large-Scale Research Actually Shows

The strongest evidence comes from a registry-based study in Sweden that compared individuals diagnosed with PCOS against those without the condition. When researchers looked at age alone, people with PCOS had more than double the risk of a premenstrual disorder. After they accounted for demographic background, socioeconomic status, obesity, and preexisting psychiatric conditions, the risk dropped but stayed clearly elevated, with PCOS still associated with about a 54 percent higher likelihood of developing a premenstrual disorder.¹ That last detail matters because it tells us this is not simply a story about depression or anxiety being misread as PMS. The connection between PCOS and premenstrual trouble held up even among people with no psychiatric history at all.

The Swedish researchers also ran a sibling comparison, looking at sisters where one had PCOS and the other did not. This design controls for the shared family environment and much of the shared genetics between siblings. The result was essentially the same: about a 61 percent higher risk of premenstrual disorders in the sibling with PCOS.¹ That sibling analysis is one of the more convincing pieces of this puzzle, because it makes it harder to argue that the link is just an artifact of growing up in a particular family or having a particular genetic background.

Smaller studies confirm the pattern from different angles. A case-control study comparing Palestinian women with and without PCOS found that the PCOS group scored significantly higher across multiple premenstrual symptom subdomains, not just in one area like mood or pain but across the board.² When studies from different populations and using different methods keep pointing the same direction, the overall picture becomes harder to dismiss.

How Severe It Gets

Knowing that PMS is more common with PCOS is one thing. Understanding how intensely it hits is another. A study of 375 married women with PCOS found that nearly half reported severe premenstrual symptoms, and another 43 percent reported moderate symptoms. Only about 8 percent fell in the mild range.³ That distribution is dramatically skewed toward the heavier end of the spectrum. In the general population, severe PMS affects a much smaller fraction of menstruating people.

The same study looked at health-related quality of life and found that about 40 percent of participants reported severe impairment. PMS severity was statistically associated with quality-of-life scores, though the explained variance was small, suggesting that PMS alone does not account for the full burden.³ In other words, PCOS brings its own quality-of-life challenges on top of premenstrual suffering. The two conditions compound each other rather than simply coexisting.

Why PCOS Makes Premenstrual Symptoms Worse

The short version is that PCOS disrupts several hormonal and metabolic systems that also happen to influence premenstrual symptoms. Rather than one clean mechanism, it is a pile-on effect where each disruption nudges the premenstrual experience in a worse direction.

Excess Androgens and Mood

PCOS is defined in part by higher-than-typical androgen levels. Those androgens do not just cause acne and unwanted hair growth; they appear to affect mood and emotional wellbeing, too. Research on Iranian women with PCOS found that a higher free androgen index was linked to worse quality-of-life scores, including in domains related to depression and menstrual irregularity. Those associations weakened after adjusting for age and body mass index, which suggests that body weight plays a mediating role, but the pattern was still there.⁴ The takeaway is that the androgen excess characteristic of PCOS likely contributes to the mood-related side of premenstrual symptoms, though it is tangled up with weight and metabolic health in ways that researchers are still working to untangle.

Inflammation and Pain Sensitivity

Chronic low-grade inflammation is a well-known feature of PCOS. Elevated markers like C-reactive protein, interleukin-6, and tumor necrosis factor alpha have been documented in women with the condition, and these inflammatory signals can sensitize pain pathways throughout the body. Insulin resistance, which affects a large proportion of people with PCOS, further amplifies this inflammatory state. On top of that, the imbalanced ratio of estrogen to progesterone that is common in PCOS can alter how the body processes pain signals.⁵ This means that premenstrual cramps, headaches, and body aches are not just psychologically amplified in PCOS; the underlying biology of pain processing is physically altered in a way that makes the same cramp genuinely hurt more.

Neurosteroid Disruption

A neurosteroid called allopregnanolone, which is derived from progesterone, plays an important role in calming brain activity by acting on receptors involved in anxiety regulation. Changes in allopregnanolone have been implicated in premenstrual dysphoric disorder and postpartum depression, and researchers are now investigating whether similar disruptions occur in PCOS. Given that PCOS alters progesterone levels and cycling, it is plausible that allopregnanolone fluctuations are also affected, potentially contributing to the mood symptoms that cluster around the premenstrual phase.⁶ This is still an area where firm conclusions are ahead of the available data, but it represents a promising direction for understanding why the mood component of PMS is so pronounced in PCOS.

The Stress Connection

People with PCOS often report higher levels of perceived stress, and there is a physiological basis for that. A study examining the stress-response system in women with PCOS found that baseline cortisol levels were not significantly different between women with and without the condition. However, there was a strong correlation between perceived stress scores and cortisol levels, as well as between stress and a pituitary hormone called ACTH that drives cortisol production.⁷ What this suggests is that the stress-response system in PCOS is not broken at baseline, but it is more tightly coupled to perceived stress. If you feel stressed, your body reacts more strongly at the hormonal level, which can feed back into anxiety, irritability, and the emotional volatility that characterizes premenstrual symptoms.

This creates a feedback loop that is worth understanding. PCOS-related concerns like weight gain, hirsutism, acne, and fertility worries generate psychological stress. That stress activates the hormonal stress axis more robustly, which worsens mood symptoms, which overlap with and amplify premenstrual distress. The stress is not imaginary, and neither is its biological amplification.

Telling PMS Apart From Everyday PCOS Symptoms

One of the tricky aspects of this overlap is diagnostic. PCOS on its own causes mood swings, bloating, fatigue, and irritability, all of which also appear on any PMS symptom checklist. For someone who already has irregular cycles, it can be genuinely hard to figure out whether a bad week is premenstrual or just a bad PCOS week.

The classic way to distinguish PMS from general mood issues is timing: PMS symptoms appear in the luteal phase (the roughly two weeks before a period) and resolve within a few days of menstruation starting. But PCOS frequently disrupts the length and predictability of cycles, which makes luteal-phase tracking unreliable. If your cycles are 45 days one month and 70 days the next, identifying a consistent premenstrual window is difficult.

This matters clinically because the treatment strategies differ. If symptoms are cyclical and tied to ovulation and the luteal phase, approaches that target the menstrual cycle (like certain hormonal treatments) make sense. If symptoms are chronic and not clearly linked to cycle phase, they may be better addressed as standalone mood or metabolic issues. Keeping a symptom diary for at least two to three months, even with irregular cycles, can help clarify the pattern. Apps that let you log both symptoms and cycle days make this easier than it used to be.

The Swedish registry study mentioned earlier is also relevant here. The elevated risk of premenstrual disorders among people with PCOS persisted whether or not they had a prior psychiatric diagnosis. Among those with existing psychiatric conditions, the risk was about 33 percent higher; among those without psychiatric history, it was about 55 percent higher.¹ The fact that the association is actually stronger in the absence of psychiatric comorbidity argues against the idea that PCOS-related PMS is merely depression being mislabeled. Something specific to PCOS itself is driving premenstrual symptoms up.

Managing PMS When You Have PCOS

Because PCOS amplifies PMS through multiple pathways, the most effective management strategies tend to be those that address PCOS itself rather than treating premenstrual symptoms in isolation. The evidence points to a few approaches worth discussing with a healthcare provider.

Insulin Sensitizers

Insulin resistance is one of the central metabolic features of PCOS, and addressing it appears to have downstream benefits. Both metformin and myo-inositol have been shown to improve insulin resistance, reduce androgen levels, and improve menstrual regularity in women with PCOS.⁸ Research has found that both treatments lowered free testosterone and glucose levels across women of varying ages and body sizes.⁹ By bringing androgen levels down and improving metabolic function, these treatments can theoretically ease the hormonal turbulence that feeds into worse premenstrual symptoms. Myo-inositol is available as a supplement and is sometimes easier to tolerate than metformin, which can cause gastrointestinal side effects.

Dietary Changes

A meta-analysis examining low glycemic index diets in women with PCOS found meaningful improvements in emotional health scores and reductions in unwanted body hair compared to control diets.¹⁰ Low glycemic index eating means choosing carbohydrates that release sugar into the bloodstream slowly rather than in sharp spikes. This reduces the insulin surges that worsen PCOS metabolically and, in turn, may blunt some of the hormonal fluctuations that intensify PMS. The emotional health improvement is particularly relevant here because mood symptoms are one of the most burdensome aspects of premenstrual syndrome in PCOS.

Exercise and Stress Management

Given the tight coupling between perceived stress and cortisol response described earlier, interventions that lower subjective stress can have real hormonal effects. Regular physical activity improves insulin sensitivity, lowers androgens modestly, and independently reduces premenstrual symptoms through endorphin release and improved sleep. There is no magic exercise prescription, but consistent moderate activity, even regular walks, has better evidence than occasional intense workouts. Stress-reduction techniques like mindfulness-based approaches may also help break the stress-cortisol-mood cycle, though the evidence base for these specifically in PCOS-related PMS is still thin.

When PMS Crosses Into PMDD

Premenstrual dysphoric disorder is a severe form of premenstrual syndrome recognized as a distinct diagnosis. Its hallmarks are debilitating mood symptoms, particularly intense irritability, depression, or anxiety that seriously interfere with work and relationships during the luteal phase. Given that PCOS already raises the risk of premenstrual disorders generally, it makes sense to be aware of when symptoms cross the line from unpleasant to disabling.

The neurosteroid pathway discussed above is particularly relevant to PMDD. Allopregnanolone fluctuations appear to play a central role in PMDD specifically, and if PCOS disrupts that pathway, the progression from bad PMS to PMDD may be more likely.⁶ PMDD responds to certain treatments, such as SSRIs taken during the luteal phase, that standard PMS management does not typically involve. If your premenstrual symptoms are causing you to miss work, withdraw from people you care about, or have thoughts of self-harm, that warrants a direct conversation with a clinician about PMDD as a separate diagnosis rather than just “really bad PMS.”

Why This Connection Has Been Understudied

For a condition that affects roughly one in ten women of reproductive age, PCOS has received surprisingly little focused research on premenstrual symptoms. Part of the reason is historical: PCOS has traditionally been studied through the lens of infertility and metabolic disease. Its effects on mood and cyclical symptoms have been treated as secondary, almost incidental. Another issue is methodological. Because PCOS causes irregular cycles, the traditional two-cycle prospective symptom charting used to diagnose PMS does not work as neatly. Researchers and clinicians may underdiagnose PMS in people with PCOS simply because the irregular cycles make the classic diagnostic criteria harder to apply.

The Swedish study’s use of a national registry was one way to get around the small-sample problem, but registry studies depend on people actually receiving a formal diagnosis, and both PCOS and premenstrual disorders are underdiagnosed conditions. It is likely that the true overlap is even larger than what the current numbers show. As researchers call for more prospective studies that track neurosteroid levels and mood symptoms across cycles in people with PCOS, the mechanistic picture should sharpen over the coming years.⁶ For now, the practical implication is clear: if you have PCOS and feel like your premenstrual symptoms are unusually bad, the evidence says you are probably right, and it is worth bringing up with whoever manages your care.

1
PubMed Central. Polycystic Ovary Syndrome and the Risk of Premenstrual Disorders: A Nationwide Register-Based Study in Sweden
2
PubMed Central. Comparison of premenstrual symptoms, psychological well-being, and nutritional status between Palestinian women with and without polycystic ovarian syndrome: a case-control study
3
Journal of Health, Wellness and Community Research. Prevalence of Premenstrual Syndrome and Its Impact on Quality of Life in Married Females With Polycystic Ovary Syndrome (PCOS)
4
PubMed Central. Mental Health Across the Menstrual Cycle in Polycystic Ovary Syndrome: Insights and Implications
5
PubMed Central. Pain in polycystic ovary syndrome: a comprehensive bedside to bench perspective on an underrecognized symptom
6
Current Psychiatry Reports. Polycystic Ovary Syndrome, Affective Symptoms, and Neuroactive Steroids: a Focus on Allopregnanolone
7
Clinical and Experimental Reproductive Medicine. Relationship between hypothalamic–pituitary–adrenal axis activity and menstrual irregularities in women with polycystic ovary syndrome
8
PubMed Central. The Comparative Effects of Myo-Inositol and Metformin Therapy on the Clinical and Biochemical Parameters of Women of Normal Weight Suffering from Polycystic Ovary Syndrome
9
Undergraduate Research in Natural and Clinical Science and Technology. Is Premenstrual Syndrome Worse With PCOS?
10
PubMed Central. The effect of low glycemic index diet on the reproductive and clinical profile in women with polycystic ovarian syndrome: A systematic review and meta-analysis